Literature DB >> 15834283

Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading.

Thomas Quaschning1, Benjamin Rebhan, Christoph Wunderlich, Christoph Wanner, Claus-Michael Richter, Thiemo Pfab, Christian Bauer, Annette Kraemer-Guth, Jan Galle, Masashi Yanagisawa, Berthold Hocher.   

Abstract

BACKGROUND: Rodents without a functional endothelin B (ETB) receptor develop salt-sensitive hypertension. The underlying mechanisms, however, are so far unknown. The ETB receptor is involved in endothelial function by modulating the activity of the endothelial nitric oxide synthesis as well as contributing to the control of endothelial prostacyclin synthesis. In the present study, we analysed whether salt alters endothelial function in rescued ETB receptor-deficient mice. We used mice with a rescue of the lethal phenotype of an ETB knockout. These mice were generated by crossbreeding ETB mice with dopamine-hydroxylase ETB transgenic mice.
METHODS: Adult rescued ETB-deficient mice were kept in parallel with wild-type control animals for 15 days on standard (0.2% NaCl) or salt-enriched (4% NaCl) chow, respectively. Systolic blood pressure was measured by the tail cuff method and endothelium-dependent and endothelium-independent vascular function was assessed in isolated aortic rings under isometric conditions.
RESULTS: Systolic blood pressure increased on salt-enriched chow in ETB receptor-deficient mice (166 +/- 12 mmHg), but neither in wild-type mice on high-salt diet (128 +/- 11 mmHg; P < 0.05) nor in ETB receptor-deficient mice on standard chow. The heart rate was similar in all groups at any point of time. Endothelium-dependent relaxation was impaired in ETB receptor-deficient mice (74 +/- 3 versus 96 +/- 5% of preconstriction for wild-type mice; P < 0.05) and was not significantly affected by a salt-enriched diet. Endothelium-independent relaxation was similar among all groups. Contractions to endothelin-1 were not significantly influenced by preincubation with the ETB receptor antagonist BQ-788, but were completely blunted by preincubation with the ETA receptor antagonist BQ-123 in all animals.
CONCLUSION: Rescued ETB receptor-deficient mice develop salt-sensitive hypertension. Nevertheless, in this animal model of ETB receptor deficiency, endothelial function is impaired independent of salt-enriched diet or hypertension. This indicates that, in this model, salt-induced hypertension is not mediated by endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834283     DOI: 10.1097/01.hjh.0000166838.55688.7e

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  Endothelin B receptor is not required but necessary for finite regulation of ovulation.

Authors:  Jongki Cho; Heyyoung Kim; Dong-Wook Kang; Masashi Yanagisawa; CheMyong Ko
Journal:  Life Sci       Date:  2012-03-03       Impact factor: 5.037

Review 2.  Endothelium-derived ET-1 and the development of renal injury.

Authors:  Carmen De Miguel; David M Pollock; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-20       Impact factor: 3.619

Review 3.  Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.

Authors:  Marc Q Mazzuca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2012-03-30       Impact factor: 5.858

4.  Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension.

Authors:  Christoph Tabeling; Carla R González Calera; Jasmin Lienau; Jakob Höppner; Thomas Tschernig; Olivia Kershaw; Birgitt Gutbier; Jan Naujoks; Julia Herbert; Bastian Opitz; Achim D Gruber; Berthold Hocher; Norbert Suttorp; Harald Heidecke; Gerd-R Burmester; Gabriela Riemekasten; Elise Siegert; Wolfgang M Kuebler; Martin Witzenrath
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 5.  Endothelin-1 and hypertension: from bench to bedside.

Authors:  Donald E Kohan
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

Review 6.  The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

Authors:  N S Kirkby; P W F Hadoke; A J Bagnall; D J Webb
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 7.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

Review 8.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

9.  Pathophysiology of the endothelin system - lessons from genetically manipulated animal models.

Authors:  K von Websky; S Heiden; T Pfab; Berthold Hocher
Journal:  Eur J Med Res       Date:  2009-01-28       Impact factor: 2.175

10.  SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.

Authors:  Lei L Chen; Jing Zhu; Jonathan Schumacher; Chongjuan Wei; Latha Ramdas; Victor G Prieto; Arnie Jimenez; Marco A Velasco; Sheryl R Tripp; Robert H I Andtbacka; Launce Gouw; George M Rodgers; Liansheng Zhang; Benjamin K Chan; Pamela B Cassidy; Robert S Benjamin; Sancy A Leachman; Marsha L Frazier
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.